Amarin Corporation PLC ROE

ROE of AMRN for past 10 years: annual, quarterly and twelve month trailing (TTM) including ROE growth rates and interactive chart. ROE is expressed as a percentage and can be calculated for any company if net income and equity are both positive numbers. Net income is calculated before dividends paid to common shareholders and after dividends to preferred shareholders and interest to lenders. A company with average equity of $10 million and earnings of $2 milion will have a ROE of 20%.


Highlights and Quick Summary

  • Annual ROE for 2021 was 1.19% (a -140.07% decrease from previous year)
  • Annual ROE for 2020 was -2.97% (a -53.01% decrease from previous year)
  • Annual ROE for 2019 was -6.32% (a -98.89% decrease from previous year)
  • Twelve month ROE ending June 30, 2022 was -16.18% (a 370.35% increase compared to previous quarter)
  • Twelve month trailing ROE increased by 4956.25% year-over-year
Trailing ROE for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
-16.18% -3.44% 1.2% -0.32%
Visit stockrow.com/AMRN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical ROE of Amarin Corporation PLC

Most recent ROEof AMRN including historical data for past 10 years.

Interactive Chart of ROE of Amarin Corporation PLC

Amarin Corporation PLC ROE for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 1.19%
2020 -2.97%
2019 -6.32%
2018 -567.8%
2017 110.45%
2016 93.18%
2015 124.03%
2014 92.17%
2013 878.28%
2012 3598.43%
2011 66.36%

Business Profile of Amarin Corporation PLC

Sector: Healthcare
Industry: Biotechnology